Your browser doesn't support javascript.
loading
Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programme.
Johansson, Isabelle; Balasubramanian, Kumar; Bangdiwala, Shrikant; Mielniczuk, Lisa; Hage, Camilla; Sharma, Sanjib Kumar; Branch, Kelley; Zhu, Jun; Kragholm, Kristian; Sliwa, Karen; Alla, Francois; Yonga, Gerald; Roy, Ambuj; Orlandini, Andres; Grinvalds, Alex; McCready, Tara; Pogosova, Nana; Störk, Stefan; McMurray, John J V; Conen, David; Yusuf, Salim.
Afiliação
  • Johansson I; Population Health Research Institute, McMaster University, Hamilton, Canada.
  • Balasubramanian K; Department of Health Research Methods, Evidence, and Impact, McMaster University Faculty of Health Sciences, Hamilton, Canada.
  • Bangdiwala S; Population Health Research Institute, McMaster University, Hamilton, Canada.
  • Mielniczuk L; Population Health Research Institute, McMaster University, Hamilton, Canada.
  • Hage C; Department of Health Research Methods, Evidence, and Impact, McMaster University Faculty of Health Sciences, Hamilton, Canada.
  • Sharma SK; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  • Branch K; Karolinska University Hospital Heart, Vascular and Neuro Theme Heart Failure Section, Stockholm, Sweden.
  • Zhu J; Karolinska Institutet Department of Medicine Cardiology Unit, Stockholm, Sweden.
  • Kragholm K; B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
  • Sliwa K; Division of Cardiology, University of Washington School of Medicine, Seattle, WA, USA.
  • Alla F; Fuwai Hospital, CAMS & PUMC, Beijing, China.
  • Yonga G; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Roy A; Cape Heart Institute, Department of Medicine and Cardiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Orlandini A; Bordeaux Population Health Research Center, Inserm, Université de Bordeaux, Bordeaux, France.
  • Grinvalds A; Prevention Department, CHU, Bordeaux, France.
  • McCready T; School of Medicine, University of Nairobi, Nairobi, Kenya.
  • Pogosova N; Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.
  • Störk S; ECLA (Estudios Clínicos Latino America), Rosario, Argentina.
  • McMurray JJV; Population Health Research Institute, McMaster University, Hamilton, Canada.
  • Conen D; Population Health Research Institute, McMaster University, Hamilton, Canada.
  • Yusuf S; National Medical Research Center of Cardiology, Moscow, Russia.
Eur J Heart Fail ; 24(9): 1478-1490, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35570198
ABSTRACT

AIMS:

To examine clinical and social correlates of health-related quality of life (HRQL) in patients with heart failure (HF) from high- (HIC), upper middle- (UMIC), lower middle- (LMIC) and low-income (LIC) countries. METHODS AND

RESULTS:

Between 2017 and 2020, 23 292 patients with HF (32% inpatients, 61% men) from 40 countries were enrolled in the Global Congestive Heart Failure study. HRQL was recorded at baseline using the Kansas City Cardiomyopathy Questionnaire (KCCQ)-12. In a cross-sectional analysis, we compared age- and sex-adjusted mean KCCQ-12 summary scores (SS 0-100, higher = better) between patients from different country income levels. We used multivariable linear regression examining correlations (estimated coefficients) of KCCQ-12-SS with sociodemographic, comorbidity, treatment and symptom covariates. The adjusted model (37 covariates) was informed by univariable findings, clinical importance and backward selection. Mean age was 63 years and 40% of patients were in New York Heart Association (NYHA) class III-IV. Average HRQL was 55 SD 27. It was 62.5 (95% confidence interval [CI] 62.0-63.1) in HIC, 56.8 (56.1-57.4) in UMIC, 48.6 (48.0-49.3) in LMIC, and 38.5 (37.3-39.7) in LICs (p < 0.0001). Strong correlates (estimated coefficient [95% CI]) of KCCQ-12-SS were NYHA class III versus class I/II (-12.1 [-12.8 to -11.4] and class IV versus class I/II (-16.5 [-17.7 to -15.3]), effort dyspnoea (-9.5 [-10.2 to -8.8]) and living in LIC versus HIC (-5.8 [-7.1 to -4.4]). Symptoms explained most of the KCCQ-12-SS variability (partial R2  = 0.32 of total adjusted R2  = 0.51), followed by sociodemographic factors (R2  = 0.12). Results were consistent in populations across income levels.

CONCLUSION:

The most important correlates of HRQL in HF patients relate to HF symptom severity, irrespective of country income level.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Insuficiência Cardíaca Idioma: En Ano de publicação: 2022 Tipo de documento: Article